Suppr超能文献

抗肿瘤药LXIV:1,4-双(2'-氯乙基)-1,4-二氮杂双环[2.2.1]庚烷二氢双马来酸酯。

Antineoplastic agents LXIV: 1,4-Bis(2'-chloroethyl)-1,4-diazabicyclo[2.2.1]heptane dihydrogen dimaleate.

作者信息

Pettit G R, Gieschen D P, Pettit W E

出版信息

J Pharm Sci. 1979 Dec;68(12):1539-42. doi: 10.1002/jps.2600681220.

Abstract

The 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo[2.2.1]heptane dication (II) exhibits remarkable antineoplastic activity. Detailed evaluation of several dianion derivatives showed a curative response level against the murine P-388 lymphocytic leukemia, colon 26, CD8F1 mammary, and the Walker 256 carcinosarcoma (rat) tumor systems. In addition, significant cancer chemotherapeutic activity was found against the murine L-1210 lymphoid leukemia, colon 38, and B16 melanocarcinoma tumor systems. The bicyclo dication (II) first was isolated, evaluated, and stored as the diperchlorate derivative (IIa). Because of the promising anticancer activity of IIa, procedures were developed for obtaining other anion derivatives for comparative biological purposes. Several naturally occurring substances were evaluated, and the dihydrogen dimaleate derivative (IIi) obtained by an ion-exchange technique was the most suitable.

摘要

1,4-双(2'-氯乙基)-1,4-二氮杂双环[2.2.1]庚烷二价阳离子(II)具有显著的抗肿瘤活性。对几种二价阴离子衍生物的详细评估表明,其对小鼠P-388淋巴细胞白血病、结肠26、CD8F1乳腺肿瘤以及Walker 256癌肉瘤(大鼠)肿瘤系统有治愈反应水平。此外,还发现其对小鼠L-1210淋巴白血病、结肠38和B16黑色素瘤肿瘤系统有显著的癌症化疗活性。双环二价阳离子(II)最初作为高氯酸二酯衍生物(IIa)被分离、评估和储存。由于IIa具有有前景的抗癌活性,因此开发了用于获得其他阴离子衍生物以进行比较生物学研究的方法。评估了几种天然存在的物质,通过离子交换技术获得的二氢马来酸酯衍生物(IIi)是最合适的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验